Complement function in mAb-mediated cancer immunotherapy

KA Gelderman, S Tomlinson, GD Ross, A Gorter - TRENDS in Immunology, 2004 - cell.com
Complement activation by mAbs can cause direct tumor cell lysis or enhance antibody-
dependent cell-mediated cytotoxicity. However, tumor cells are protected from complement …
被引用次数：364 相关文章
[PDF] betaglucandata.com

[PDF][PDF] Complement function in mAb-mediated cancer immunotherapy

KA Gelderman, S Tomlinson, GD Ross… - TRENDS in …, 2004 - betaglucandata.com
Complement activation by mAbs can cause direct tumor cell lysis or enhance antibody-
dependent cell-mediated cytotoxicity. However, tumor cells are protected from complement …
[PDF] psu.edu

[PDF][PDF] Complement function in mAb-mediated cancer immunotherapy

KA Gelderman, S Tomlinson, GD Ross… - TRENDS in Immunology, 2004 - Citeseer
Complement activation by mAbs can cause direct tumor cell lysis or enhance antibody-
dependent cell-mediated cytotoxicity. However, tumor cells are protected from complement …
[PDF] academia.edu

[PDF][PDF] Complement function in mAb-mediated cancer immunotherapy

KA Gelderman, S Tomlinson, GD Ross… - TRENDS in …, 2004 - academia.edu
Complement activation by mAbs can cause direct tumor cell lysis or enhance antibody-
dependent cell-mediated cytotoxicity. However, tumor cells are protected from complement …

[引用][C] Complement function in mAb-mediated cancer immunotherapy

KA Gelderman, S Tomlinson, GD Ross, A Gorter - Trends in Immunology, 2004 - cir.nii.ac.jp
[PDF] sofislife.com

[PDF][PDF] Complement function in mAb-mediated cancer immunotherapy

KA Gelderman, S Tomlinson, GD Ross… - TRENDS in …, 2004 - sofislife.com
Complement activation by mAbs can cause direct tumor cell lysis or enhance antibody-
dependent cell-mediated cytotoxicity. However, tumor cells are protected from complement …

Complement function in mAb-mediated cancer immunotherapy

KA Gelderman, S Tomlinson, GD Ross, A Gorter - Trends in Immunology, 2004 - Elsevier
Complement activation by mAbs can cause direct tumor cell lysis or enhance antibody-
dependent cell-mediated cytotoxicity. However, tumor cells are protected from complement …

Complement function in mAb-mediated cancer immunotherapy

KA Gelderman, S Tomlinson, GD Ross, A Gorter - Trends in Immunology, 2004 - infona.pl
Complement activation by mAbs can cause direct tumor cell lysis or enhance antibody-
dependent cell-mediated cytotoxicity. However, tumor cells are protected from complement …
[PDF] researchgate.net

[PDF][PDF] Complement function in mAb-mediated cancer immunotherapy

KA Gelderman, S Tomlinson, GD Ross… - TRENDS in …, 2004 - researchgate.net
Complement activation by mAbs can cause direct tumor cell lysis or enhance antibody-
dependent cell-mediated cytotoxicity. However, tumor cells are protected from complement …

[引用][C] Complement function in mAb-mediated cancer immunotherapy

KA Gelderman, S Tomlinson… - Trends in …, 2004 - pubmed.ncbi.nlm.nih.gov
Complement function in mAb-mediated cancer immunotherapy Complement function in mAb-mediated
cancer immunotherapy Trends Immunol. 2004 Mar;25(3):158-64. doi: 10.1016/j.it.2004.01.008 …